Interleukin Genetics

Biotechnology ResearchMassachusetts, United States11-50 Employees

Interleukin Genetics, Inc. operates in the biotechnology research sector, developing and marketing genetic testing products focused on chronic inflammatory conditions and related health issues. Its offerings aim to provide genetics-based insights that help individuals and healthcare providers manage prevention and treatment of chronic diseases, with an emphasis on inflammation and metabolism. The company's portfolio includes the ILUSTRA Inflammation Management Program, which analyzes gene variations linked to inflammation from a cheek swab sample, and the Inherent Health line of genetic tests that address weight management and nutritional needs. The target market comprises employers, health plans, and healthcare organizations seeking to enhance wellness programs and preventive care through personalized information, including partnerships to offer ILUSTRA to employees and members. Based in Waltham, Massachusetts, Interleukin Genetics has a presence in the broader life sciences landscape and operates within an ecosystem of genetics-focused testing providers. A notable development in its history involves strategic activity around the ILUSTRA program and collaborations to expand access through employer-based benefits, reflecting its positioning as a provider of genetics-driven inflammation management and health optimization tools.

Sign up for free to view info

Email Format Employee directory